HARUTYI MURAVU: Open Payments
NPI 1144895251 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 5 payments from 4 companies in 2025. Trend: 2023 $466 · 2024 $249 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $241 |
| E.R. Squibb & Sons, L.L.C. | 1 | $129 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
Products named: INGREZZA, COBENFY, ABILIFY MAINTENA, UZEDY.
Industry payments across NC — which companies pay providers there.
